In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development: Current Status and Future Directions

By Pelkonen Olavi  

Clinical Pharmacokinetics, Vol. 50, Iss. 8, 2011-08 ,pp. : 483-491

Adis International

Access to resources Recommend Favorite

Computational prediction of local drug effect on carcinogenic acetaldehyde in the mouth based on in vitro/in vivo results of freely soluble l-cysteine

By Kartal Alma   Marvola Janne   Matheka Jenni   Peltoniemi Marikki   Sivén Mia  

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 6, 2010-06 ,pp. : 715-723

Informa Healthcare

Access to resources Recommend Favorite

The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro–in vivo extrapolation of drug clearance and drug-drug interaction potential

By Miners John O.   Mackenzie Peter I.   Knights Kathleen M.  

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 196-208

Informa Healthcare

Access to resources Recommend Favorite

A population approach to in vitro–in vivo correlation modelling for compounds with nonlinear kinetics

By Gaynor Clare   Dunne Adrian   Costello Cian   Davis John  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 38, Iss. 3, 2011-06 ,pp. : 317-332

Springer Publishing Company

Access to resources Recommend Favorite

Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation

By  

Current Drug Metabolism, Vol. 17, Iss. 5, 2016-06 ,pp. : 456-468

Bentham Science Publishers

Access to resources Recommend Favorite